Nanoparticles based on artificial self-assembling peptide and displaying M2e peptide and stalk HA epitopes of influenza A virus induce potent humoral and T-cell responses and protect against the viral infection

Nanomedicine. 2022 Jan:39:102463. doi: 10.1016/j.nano.2021.102463. Epub 2021 Sep 26.

Abstract

The extracellular domain of the M2 protein (M2e) and conserved region of the second subunit of the hemagglutinin (HA2) could be used for the development of broad-spectrum vaccines against influenza A. Here we obtained and characterized recombinant mosaic proteins containing tandem copies of M2e and HA2 fused to an artificial self-assembling peptide (SAP). The inclusion of SAP peptides in the fusion proteins enabled their self-assembly in vitro into spherical particles with a size of 30-50 nm. Intranasal immunization of mice with these particles without additional adjuvants induced strong humoral immune response against M2e and the whole virus. Particles carrying both M2e and HA2 induced antigen-specific multifunctional CD4+ effector memory T cells. Immunization provided high protection of mice against the lethal challenge with different subtypes of influenza A virus. The obtained self-assembling nanoparticles can be used to develop a universal influenza vaccine.

Keywords: Hemagglutinin; Influenza; M2e peptide; Nanoparticle; Recombinant vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Viral
  • Epitopes
  • Influenza A virus*
  • Influenza Vaccines*
  • Mice
  • Mice, Inbred BALB C
  • Nanoparticles*
  • Orthomyxoviridae Infections* / prevention & control
  • Peptides
  • Vaccines, Synthetic
  • Viral Matrix Proteins / genetics

Substances

  • Antibodies, Viral
  • Epitopes
  • Influenza Vaccines
  • Peptides
  • Vaccines, Synthetic
  • Viral Matrix Proteins